Loading…
Loading…
MRND (IQ U.S. Mid Cap R&D Leaders ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
The second full week of December saw a ramp-up in activity, with 20 launches and several closures. Newcomer ETF issuer Themes ETFs alone rolled out 8 new thematic ETFs.
We have recently received three new ETFs built on the concept of R&D.
Smaller equities are following their large-cap counterparts lower this year, perhaps giving investors reason to overlook mid-cap stocks. However, that may be the wrong course of action.
The U.S. exchange-traded fund (ETF) industry had quite a year in 2021 – due in part to the 445 new ETFs that launched, 44% more than did in 2020. U.S. ETFs ended the year with record assets of $7.21 trillion, 31.9% higher 2020.
New York Life's ETF brand is targeting companies that spend big on research.
IndexIQ has expanded its ETF product lineup with the launch of three new equity-focused strategies. The new trio of funds — the IQ U.S. Large Cap R&D Leaders ETF (LRND), the IQ U.S. Mid Cap R&D Leaders ETF (MRND), and the IQ Global Equity R&D Leaders ETF (WRND) — launched on the NYSE on February 8.
SEC filings for MRND aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.